Samsara BioCapital, LLC Diversified Active

Location: Palo Alto, CA

CIK: 0001744967 · Show all filings

Period: Q1 2019 (← Previous) (Next →)

Filing Date: May 15, 2019

Total Value: $127M (100.0% shares, 0.0% debt)

Holdings (18)

— Intercept Pharmaceuticals Inc 18.5%

Value $23.59M Shares 210,937 Est. Cost $100.79 Unrealized —

— Allakos Inc 14.2%

Value $18.1M Shares 446,905 Est. Cost $52.27 Unrealized —

— Odonate Therapeutics Inc 10.4%

Value $13.17M Shares 595,850 Est. Cost $14.08 Unrealized —

— Principia Biopharma Inc 10.2%

Value $13.04M Shares 383,480 Est. Cost $27.39 Unrealized —

— Sutro BioPharma Inc 10.1%

Value $12.82M Shares 1,125,579 Est. Cost $9.02 Unrealized —

GOSS Gossamer Bio Inc 9.1%

Value $11.55M Shares 532,920 Est. Cost $20.85 Unrealized 0.0%

— Syros Pharmaceuticals Inc 7.6%

Value $9.688M Shares 1,059,938 Est. Cost $5.57 Unrealized —

LQDA Liquidia Technologies Inc 5.7%

Value $7.275M Shares 639,290 Est. Cost $20.38 Unrealized -21.4%

— Sunesis Pharmaceuticals Inc 3.6%

Value $4.556M Shares 3,750,000 Est. Cost $1.21 Unrealized —

KALV KalVista Pharmaceuticals Inc 2.7%

Value $3.391M Shares 118,500 Est. Cost $20.10 Unrealized +7.8%

— Aravive Inc 2.4%

Value $3.117M Shares 442,733 Est. Cost $3.52 Unrealized —

— Catabasis Pharmaceuticals Inc 1.9%

Value $2.376M Shares 300,000 Est. Cost $4.37 Unrealized —

— Evelo Biosciences Inc 1.4%

Value $1.82M Shares 227,529 Est. Cost $13.01 Unrealized —

UROV Urovant Sciences Ltd 1.2%

Value $1.583M Shares 157,480 Est. Cost $6.59 Unrealized —

— Millendo Therapeutics Inc 0.5%

Value $677K Shares 45,101 Est. Cost $7.96 Unrealized —

— Surface Oncology Inc 0.3%

Value $373K Shares 78,300 Est. Cost $4.24 Unrealized —

PDSB PDS Biotechnology Corp 0.1%

Value $68,000 Shares 9,166 Est. Cost $8.36 Unrealized 0.0%

— Trillium Therapeutics Inc 0.0%

Value $47,000 Shares 71,619 Est. Cost $1.70 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	Intercept Pharmaceuticals Inc	210,937	$23.59M	18.5%	$100.79	—	COM	45845P108
—	Allakos Inc	446,905	$18.1M	14.2%	$52.27	—	COM	01671P100
—	Odonate Therapeutics Inc	595,850	$13.17M	10.4%	$14.08	—	COM	676079106
—	Principia Biopharma Inc	383,480	$13.04M	10.2%	$27.39	—	COM	74257L108
—	Sutro BioPharma Inc	1,125,579	$12.82M	10.1%	$9.02	—	COM	869367102
GOSS	Gossamer Bio Inc	532,920	$11.55M	9.1%	$20.85	0.0%	COM	38341P102
—	Syros Pharmaceuticals Inc	1,059,938	$9.688M	7.6%	$5.57	—	COM	87184Q107
LQDA	Liquidia Technologies Inc	639,290	$7.275M	5.7%	$20.38	-21.4%	COM	53635D202
—	Sunesis Pharmaceuticals Inc	3,750,000	$4.556M	3.6%	$1.21	—	COM	867328700
KALV	KalVista Pharmaceuticals Inc	118,500	$3.391M	2.7%	$20.10	+7.8%	COM	483497103
—	Aravive Inc	442,733	$3.117M	2.4%	$3.52	—	COM	03890D108
—	Catabasis Pharmaceuticals Inc	300,000	$2.376M	1.9%	$4.37	—	COM	14875P206
—	Evelo Biosciences Inc	227,529	$1.82M	1.4%	$13.01	—	COM	299734103
UROV	Urovant Sciences Ltd	157,480	$1.583M	1.2%	$6.59	—	COM	G9381B108
—	Millendo Therapeutics Inc	45,101	$677K	0.5%	$7.96	—	COM	60040X103
—	Surface Oncology Inc	78,300	$373K	0.3%	$4.24	—	COM	86877M209
PDSB	PDS Biotechnology Corp	9,166	$68,000	0.1%	$8.36	0.0%	COM	70465T107
—	Trillium Therapeutics Inc	71,619	$47,000	0.0%	$1.70	—	COM	89620X506